ASX:PCL
ASX:PCLOil and Gas

3 ASX Penny Stocks With Market Caps Under A$2B To Consider

The Australian market has experienced a fairly uneventful day, with negative sentiment lingering due to last week's higher-than-expected CPI figures from the ABS. This has temporarily decoupled Australia's market performance from Wall Street's more optimistic trends. Despite this backdrop, penny stocks remain an intriguing area for investors seeking opportunities outside the mainstream indices. Although the term 'penny stock' might seem outdated, these smaller or newer companies can still...
ASX:NCK
ASX:NCKSpecialty Retail

Nick Scali (ASX:NCK): Assessing Valuation After Robust FY25 Results and UK Expansion Boost

Nick Scali (ASX:NCK) has captured investor attention by announcing strong results for fiscal year 2025, along with a successful UK acquisition that positions the company for further international growth. The new leadership structure also signals a refreshed strategic direction. See our latest analysis for Nick Scali. Nick Scali’s shares have soared to a record high, rising rapidly on the back of strong profit results and UK expansion news, with a 90-day share price return of nearly 30%...
ASX:360
ASX:360Software

Life360 (ASX:360) Expands Into Pet Safety: What the New Pet GPS Means for Its Valuation

Life360 (ASX:360) is expanding its family safety platform with the launch of Life360 Pet GPS, a tracking device and suite of new app features designed to help families monitor and protect their pets. This move aims to drive greater engagement by integrating pets into the company’s growing connected community. See our latest analysis for Life360. Life360’s share price has had an impressive run, jumping 124.7% year-to-date and closing at $50.76. This reflects growing market confidence following...
ASX:MP1
ASX:MP1IT

Megaport (ASX:MP1) Is Up 9.6% After Upgrading FY26 Revenue on Network and Partnership Gains – What’s Changed

Megaport Limited recently reported strong fiscal year 2025 results, including Annual Recurring Revenue of A$243.8 million and the enablement of over 1,000 data centers, while also revising its fiscal year 2026 revenue projections upward. The company's upgraded outlook is underpinned by new strategic partnerships that are expanding Megaport's global network and supporting ongoing growth initiatives. We'll explore how Megaport's revised revenue outlook, supported by network expansion, affects...
ASX:CUV
ASX:CUVBiotechs

Clinuvel Pharmaceuticals (ASX:CUV): Valuation Insights After SEC Review Delay and Share Price Dip

Clinuvel Pharmaceuticals (ASX:CUV) shared that the ongoing U.S. Federal government shutdown is expected to slow the review and approval of its SEC filings. The company’s share price slipped following news of the delay. See our latest analysis for Clinuvel Pharmaceuticals. Clinuvel’s share price has steadily softened this year, with a 30-day share price return of -10.26% hinting at fading momentum. Ongoing SEC-related delays are adding to the pressure. The bigger picture shows a one-year total...
ASX:CSL
ASX:CSLBiotechs

Why CSL (ASX:CSL) Is Down 17.0% After Board Changes and Lowered Revenue Growth Guidance

At its October 2025 Annual General Meeting, CSL Limited announced the retirement of Dr. Megan Clark and Ms. Marie McDonald from the Board, while appointing Mr. Costa Saroukis and Mr. Gordon Naylor as new Directors effective December 1, 2025. The leadership transition coincided with lowered revenue growth guidance for financial year 2026, signaling a period of recalibration in CSL's strategy as it aligns board expertise with shifts in the business outlook. We'll explore how CSL's revised...
ASX:BBL
ASX:BBLEntertainment

3 Promising ASX Penny Stocks With Over A$90M Market Cap

As the Australian market steadies ahead of a significant Reserve Bank rate decision, investors are navigating a landscape marked by stable indices and cautious optimism. Penny stocks, often seen as relics of past market eras, continue to offer intriguing opportunities for growth through smaller or newer companies. With strong financial health and solid fundamentals, these stocks can provide a unique mix of affordability and potential returns.
ASX:WBC
ASX:WBCBanks

Westpac (ASX:WBC) Margin Decline Reinforces Concerns Over Premium Valuation

Westpac Banking (ASX:WBC) reported earnings growth of 3.93% per year, with revenue tracking slightly behind at 3.6% per year. The company’s current net profit margin is 31.5%, reflecting a modest decline from last year's 33.2%. Over the last five years, Westpac delivered a solid 12.4% annualized earnings growth, and its earnings quality remains high, although growth forecasts suggest the bank will lag the broader Australian market. See our full analysis for Westpac Banking. Next up, we’ll see...